KADIAN 200 mg (Morphine sulfate extended release 200 mg)
Pill imprint KADIAN 200 mg has been identified as Morphine sulfate extended release 200 mg.
Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 200 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Morphine sulfate extended release
- Imprint:
- KADIAN 200 mg
- Strength:
- 200 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Actavis
More about morphine
Consumer resources
- Morphine
- Morphine concentrate
- Morphine extended-release capsules
- Morphine immediate-release
- Morphine immediate-release tablets
- More (8) »
- Other brands: MS Contin, Kadian, Roxanol, Avinza, More (7) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
